Emerging data suggests that temozolomide chemotherapy may be a viable alternative to radiation therapy for older patients with MGMT-methylated tumours who cannot benefit from a combined-modality approach due to poor functional status or significant comorbidity. This evidence concerns the gene MGMT and neoplasm.